Knockdown/inhibition of TPPP3 has resulted in decreased proliferation and cell cycle arrest in various human and mouse tumour cell lines (Li et al., 2016; Oláh et al., 2022), suggesting it may play a role in the observed alterations to NSC proliferation. This evidence concerns the gene TPPP3 and neoplasm.